Found 18 matching trials
Phase II Study of NGR-hTNF Versus Placebo as Maintenance Treatment in Patients With Advanced MPM
PHASE2The main objective of the trial is to document the efficacy of NGR-hTNF adm...
Location
Zentralklinik Bad Berka GmbH
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Metastatic Small Cell Lung Carcinoma
PHASE2The main objective of the trial is to document the progression free surviva...
Location
Istituto Clinico Humanitas
Study of NGR-hTNF as Single Agent in Patients Affected by Advanced or Metastatic Hepatocellular Carcinoma (HCC)
PHASE2The main objective of the trial is to document the progression free surviva...
Location
Fondazione San Raffaele del Monte Tabor
NGR-hTNF in Combination With Standard Chemotherapy to Treat Patients With Advanced Non-small Cell Lung Cancer
PHASE2The main objective of this study is to demonstrate superiority in progressi...
Location
Istituto Nazionale per la ricerca sul cancro
Study of NGR-hTNF in Combination With Doxorubicin in Patients Affected by Advanced or Metastatic Ovarian Cancer
PHASE2The main objective of the trial is to document the response rate in patient...
Location
Fondazione San Raffaele del Monte Tabor
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
PHASE2The primary objective of this randomized phase II trial is to compare progr...
Location
Ospedale San Raffaele
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
PHASE1The main objective of the trial is to document the safety of the combinatio...
Location
Istituto Clinico Humanitas
Study of NGR-hTNF as Single Agent in Patients Affected by Colorectal Cancer (CRC)
PHASE2The main objective of the trial is to document the progression free surviva...
Location
Istituto Clinico Humanitas
NGR015: Study in Second Line for Patient With Advanced Malignant Pleural Mesothelioma Pretreated With Pemetrexed
PHASE3The main objective of the trial is to document the efficacy of NGR-hTNF adm...
Location
Wilshire Oncology Medical Group
Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour
PHASE1The main objective of the trial is to document the safety and antivascular ...
Location
Istituto Clinico Humanitas